Studying the Effects of Sibutramine on Eating Behavior

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Obesity

In brief

Obesity is a major public health concern, and the search for useful pharmacologic interventions is ongoing. This study aims to develop a comprehensive series of assessments to directly assess eating behavior, cognitive functioning, and psychological functioning under sibutramine and placebo conditions.

Key facts

Study ID
NCT01170364
Run by
New York State Psychiatric Institute
People needed
14
Starts
2009-02-01
Expected to finish
2010-10-01
Last updated by the study team
2017-08-30

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.